Meniere’s Treatment Report

www.MenieresTreatmentReport.com

Clinical Trials

Modulating Auditory Symptoms and Vertigo of Meniere’s Disease by Non-invasive Mastoid Electric Stimulation

CATEGORY:
Clinical Trials

TITLE:
Modulating Auditory Symptoms and Vertigo of Meniere’s Disease by Non-invasive Mastoid Electric Stimulation

INTERVENTION/TREATMENT:

PHASE:

DESCRIPTION:
Condition :   Meniere’s Disease

Interventions :   Device: YPS-201b;   Drug: betahistine

Sponsor :   Seoul National University Hospital

Recruiting

ID:
NCT06001593

STATUS:

DATE – FIRST POSTED:
Mon, 21 Aug 2023 12:00:00 EDT

DATE – LAST UPDATE POSTED:
08/21/23 09:20AM

DATE – ADDED:
08/21/23 09:20AM

LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT06001593

LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT06001593

http://classic.clinicaltrials.gov/ct2/show/NCT06001593

REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-08-21T13:20:25+00:00, https://www.menierestreatmentreport.com.

The CAVA Multicentre Dizziness Trial

CATEGORY:
Clinical Trials

TITLE:
The CAVA Multicentre Dizziness Trial

INTERVENTION/TREATMENT:

PHASE:

DESCRIPTION:
Conditions :   Ménière’s Disease;   Vestibular Migraine;   Benign Paroxysmal Positional Vertigo (BPPV)

Intervention :   Device: The continuous ambulatory vestibular assessment (CAVA) system

Sponsors :   Norfolk and Norwich University Hospitals NHS Foundation Trust;   University Hospitals, Leicester;   St George’s University Hospitals NHS Foundation Trust;   Gloucestershire Hospitals NHS Foundation Trust;   University Hospital Birmingham NHS Foundation Trust;   Mid and South Essex NHS Foundation Trust;   Guy’s and St Thomas’ NHS Foundation Trust

Recruiting

ID:
NCT05984901

STATUS:

DATE – FIRST POSTED:
Wed, 09 Aug 2023 12:00:00 EDT

DATE – LAST UPDATE POSTED:
08/09/23 08:39AM

DATE – ADDED:
08/09/23 08:39AM

LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT05984901

LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT05984901

http://classic.clinicaltrials.gov/ct2/show/NCT05984901

REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-08-09T12:39:40+00:00, https://www.menierestreatmentreport.com.

Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand

CATEGORY:
Clinical Trials

TITLE:
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand

INTERVENTION/TREATMENT:

PHASE:

DESCRIPTION:
Conditions :   Vertigo;   BPPV;   Meniere Disease;   Labrynthitis;   Vestibular Disorder;   Vestibular Migraine;   Benign Paroxysmal Positional Vertigo;   Ménière’s Vertigo

Interventions :   Device: Otoband Experimental;   Device: Otoband Sham

Sponsors :   Otolith Labs;   MCRA

Recruiting

ID:
NCT05960786

STATUS:

DATE – FIRST POSTED:
Thu, 27 Jul 2023 12:00:00 EDT

DATE – LAST UPDATE POSTED:
07/27/23 09:11AM

DATE – ADDED:
07/27/23 09:11AM

LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT05960786

LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT05960786

http://classic.clinicaltrials.gov/ct2/show/NCT05960786

REFERENCE:
Meniere’s Treatment Report, Urgent Research, 2023-07-27T13:11:50+00:00, https://www.menierestreatmentreport.com.

Ménière’s Disease Registry (MDR) [Observational]

https://clinicaltrials.gov/ct2/show/NCT04438538

Go to sections
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Risk Factors for the Development of Bilateral Ménière’s Disease and the Establishment of a National Ménière’s Disease Registry.
Actual Study Start Date : June 20, 2020
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : February 1, 2021

A Study of a Mastoid Device in Subjects With Ménière’s Disease

https://clinicaltrials.gov/ct2/show/NCT03520322?type=Intr&cond=Meniere+Disease&lupd_s=01%2F29%2F2019&lupd_d=14

Condition :   Meniere Disease

Interventions :   Device: Mastoid Oscillator;   Device: Control Device

Sponsor :   University of Rochester

Enrolling by invitation

A Study of a Mastoid Device in Subjects With Ménière’s Disease

NCT03520322

Wed, 09 May 2018 12:00:00 EDT

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes

https://clinicaltrials.gov/ct2/show/NCT04218123?type=Intr&cond=Meniere+Disease&lupd_s=12%2F23%2F2019&lupd_d=14

Condition :   Meniere Disease

Interventions :   Drug: Venlafaxine;   Drug: Placebo oral tablet

Sponsors :   Medical University of South Carolina;   American Hearing Research Foundation

Not yet recruiting

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes

NCT04218123

Mon, 06 Jan 2020 12:00:00 EST

SPI-1005 for the Treatment of Patients With Meniere’s Disease [Completed]

https://clinicaltrials.gov/ct2/show/NCT03325790?type=Intr&cond=Meniere+Disease&lupd_s=06%2F04%2F2019&lupd_d=14

Condition :   Meniere’s Disease

Interventions :   Drug: 200mg SPI-1005 BID;   Drug: 400mg SPI-1005 BID;   Other: Placebo

Sponsor :   Sound Pharmaceuticals, Incorporated

Completed

SPI-1005 for the Treatment of Patients With Meniere’s Disease

NCT03325790

Mon, 30 Oct 2017 12:00:00 EDT

Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease

https://clinicaltrials.gov/ct2/show/NCT03795675?type=Intr&cond=Meniere+Disease&lupd_s=02%2F28%2F2019&lupd_d=14

Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease

Conditions :   Vestibular Schwannoma;   Meniere Disease

Intervention :   Device: Cochlear Implant

Sponsors :   Ohio State University;   Advanced Bionics

Recruiting

CI Following VS Removal or Labyrinthectomy

NCT03795675

Tue, 08 Jan 2019 12:00:00 EST

Back to top